Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Wei, Wei ^a   An, Xing Rong ^a   Jin, Shi Jie ^b   Li, Xiao Xue ^c   Xu, Ming ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; PALMITIC ACID; PROSTAGLANDIN E1;

ANIMAL; AUTOPHAGY; CELL SURVIVAL; DIABETIC NEPHROPATHY; DISEASE MODEL; DRUG EFFECT; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION TEST; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; RAT; SIGNAL TRANSDUCTION;

ALPROSTADIL; ANIMALS; AUTOPHAGY; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTORS; GLUCOSE; HUMANS; INSULIN RESISTANCE; KIDNEY FUNCTION TESTS; PALMITIC ACID; RATS; SIGNAL TRANSDUCTION;

EID: 85040464902     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-18427-2     Document Type: Article

References (58)

1. Gnudi, L., Coward, R. J. & Long, D. A. Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms. Trends Endocrinol Metab 27, 820-830, https://doi. org/10. 1016/j. tem. 2016. 07. 002 (2016).
2. Nerpin, E. et al. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 31, 1550-1555, https://doi. org/10. 2337/dc08-0369 (2008).
3. Parvanova, A. I. et al. Insulin Resistance and Microalbuminuria: A Cross-Sectional, Case-Control Study of 158 Patients With Type 2 Diabetes and Different Degrees of Urinary Albumin Excretion. Diabetes 55, 1456-1462, https://doi. org/10. 2337/db05-1484 (2006).
4. Kim, Y. et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes research and clinical practice 52, 145-152 (2001).
5. Sarafidis, P. A. & Ruilope, L. M. Insulin resistance, microalbuminuria, and chronic kidney disease. Current hypertension reports 10, 249 (2008).
6. Mizushima, N. Autophagy: process and function. Genes Dev 21, 2861-2873, https://doi. org/10. 1101/gad. 1599207 (2007).
7. Xu, D. et al. Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes. Acta Pharmacol Sin 35, 1215-1225, https://doi. org/10. 1038/aps. 2014. 39 (2014).
8. Sailaja Devi, M. M. & Das, U. N. Effect of prostaglandins against alloxan-induced diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 74, 39-60, https://doi. org/10. 1016/j. plefa. 2005. 09. 003 (2006).
9. Bevegård, S. & Orö, L. Effect of prostaglandin E1 on forearm blood flow. Scandinavian journal of clinical and laboratory investigation 23, 347-353 (1969).
10. Zhao, L. Lu, J. Wang, C. Zhao, W. Qing, E. Ma, J. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting. J Cardiothorac Vasc Anesth 27, 208-1211, https://doi. org/10. 1053/j. jvca. 2013. 07. 001 (2013).
11. Ninomiya, Y. & Arakawa, M. Renal effects of prostaglandin E1 in type 2 (non-insulin-dependent) diabetic patients with subclinical nephropathy. Diabetes Research 10, 129-134 (1989).
12. Okada, S. et al. Effect of prostaglandin E1 on the renin-aldosterone system in patients with diabetic nephropathy. Journal of International Medical Research 21, 126 (1993).
13. Sears, B. & Perry, M. The role of fatty acids in insulin resistance. Lipids Health Dis 14, 121, https://doi. org/10. 1186/s12944-015-0123-1 (2015).
14. Boden, G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Experimental and clinical endocrinology & diabetes 111, 121-124 (2003).
15. Khan, M. J. et al. Inhibition of autophagy rescues palmitic acid-induced necroptosis of endothelial cells. J Biol Chem 287, 21110-21120, https://doi. org/10. 1074/jbc. M111. 319129 (2012).
16. Xin, W. et al. Acetyl-CoA carboxylase 2 suppression rescues human proximal tubular cells from palmitic acid induced lipotoxicity via autophagy. Biochem Biophys Res Commun 463, 364-369, https://doi. org/10. 1016/j. bbrc. 2015. 05. 070 (2015).
17. Zhu, S. et al. Inhibition of Kupffer Cell Autophagy Abrogates Nanoparticle-Induced LiverInjury. Adv Healthc Mater 6, https://doi. org/10. 1002/adhm. 201601252 (2017).
18. Wei, Y. M. et al. Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem 31, 925-937, https://doi. org/10. 1159/000350111 (2013).
19. Kim, K. H. et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med 19, 83-92, https://doi. org/10. 1038/nm. 3014 (2013).
20. Brown, N. J. & Vaughan, D. E. Angiotensin-converting enzyme inhibitors. Circulation 97, 1411-1420 (1998).
21. Malik, R. A. et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. The Lancet 352, 1978-1981, https://doi. org/10. 1016/s0140-6736(98)02478-7 (1998).
22. Lewis, E. J. et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. New England Journal of Medicine 345, 851-860 (2001).
23. Patel, A. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. The Lancet 370, 829-840, https://doi. org/10. 1016/ s0140-6736(07)61303-8 (2007).
24. Bilous, R. et al. Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in DiabetesThree Randomized Trials. Annals of internal medicine 151, 11-20 (2009).
25. Vargas, A. V., Krishnamurthi, V., Masih, R., Robinson, A. V. & Schulak, J. A. Prostaglandin E1 attenuation of ischemic renal reperfusion injury in the rat. Journal of the American College of Surgeons 180, 713-717 (1995).
26. Schneider, A. et al. Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: Possible role of TGF?. Kidney international 50, 190-199 (1996).
27. Sun, D., Liu, C. X., Ma, Y. Y. & Zhang, L. Protective effect of prostaglandin E1 on renal microvascular injury in rats of acute aristolochic acid nephropathy. Ren Fail 33, 225-232, https://doi. org/10. 3109/0886022X. 2010. 541586 (2011).
28. Boden, G. Obesity and free fatty acids. Endocrinol Metab Clin North Am 37, 635-646, viii-ix, https://doi. org/10. 1016/j. ecl. 2008. 06. 007 (2008).
29. Okumura, T., Kanemaki, T. & Kitade, H. Stimulation of glucose incorporation into glycogen by E-series prostaglandins in cultured rat hepatocytes. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1176, 137-142 (1993).
30. Kroemer, G., Marino, G. & Levine, B. Autophagy and the integrated stress response. Mol Cell 40, 280-293, https://doi. org/10. 1016/j. molcel. 2010. 09. 023 (2010).
31. Yamahara, K. et al. The role of autophagy in the pathogenesis of diabetic nephropathy. J Diabetes Res 2013, 193757, https://doi. org/10. 1155/2013/193757 (2013).
32. Niso-Santano, M. et al. Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. Autophagy 11, 575-577, https://doi. org/10. 1080/15548627. 2015. 1017222 (2015).
33. Fang, Y., Zhang, H., Zhong, Y. & Ding, X. Prolyl hydroxylase 2 (PHD2) inhibition protects human renal epithelial cells and mice kidney from hypoxia injury. Oncotarget 7, 54317 (2016).
34. Zhao, X. et al. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells. Int J Mol Med 35, 684-692, https://doi. org/10. 3892/ijmm. 2014. 2052 (2015).
35. Zhang, N., Cao, M. M., Liu, H., Xie, G. Y. & Li, Y. B. Autophagy regulates insulin resistance following endoplasmic reticulum stress in diabetes. J Physiol Biochem 71, 319-327, https://doi. org/10. 1007/s13105-015-0384-1 (2015).
36. Shi, L. et al. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1alpha-Sirt3 signaling pathway. Endocrine 50, 378-389, https://doi. org/10. 1007/s12020-015-0599-5 (2015).
37. Hartleben, B. et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120, 1084-1096, https://doi. org/10. 1172/JCI39492 (2010).
38. Kimura, T. et al. Autophagy protects kidney proximal tubule epithelial cells from mitochondrial metabolic stress. Autophagy 9, 1876-1886, https://doi. org/10. 4161/auto. 25418 (2013).
39. Yamahara, K. et al. Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J Am Soc Nephrol 24, 1769-1781, https://doi. org/10. 1681/ASN. 2012111080 (2013).
40. Yoshizaki, T. Autophagy in Insulin Resistance. Anti-Aging Medicine 9, 180-184 (2012).
41. Li, K. et al. The effects of fibroblast growth factor-21 knockdown and over-expression on its signaling pathway and glucose-lipid metabolism in vitro. Mol Cell Endocrinol 348, 21-26, https://doi. org/10. 1016/j. mce. 2011. 07. 026 (2012).
42. Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J Clin Invest 115, 1627-1635, https://doi. org/10. 1172/JCI23606 (2005).
43. Kim, H. W. et al. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice. Endocrinology 154, 3366-3376, https://doi. org/10. 1210/en. 2012-2276 (2013).
44. Zhang, C. et al. Attenuation of hyperlipidemia-and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation. PloS one 8, e82275 (2013).
45. Brooks, N. E. et al. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and beta-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice. Growth Horm IGF Res 30-31, 22-30, https://doi. org/10. 1016/j. ghir. 2016. 08. 003 (2016).
46. Wang, H., Deng, J. L., Yue, J., Li, J. & Hou, Y. B. Prostaglandin E1 for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev, CD006872, https://doi. org/10. 1002/14651858. CD006872. pub2 (2010).
47. Luo, C. et al. Therapeutic effect of alprostadil in diabetic nephropathy: possible roles of angiopoietin-2 and IL-18. Cell Physiol Biochem 34, 916-928, https://doi. org/10. 1159/000366309 (2014).
48. Lee, N. et al. Effect of misoprostol (PGE1) on glucose metabolism in type?2?diabetic and control subjects. Diabetes, Obesity and Metabolism 4, 195-200 (2002).
49. Jocks, T. et al. Prostaglandin E1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody-induced glomerular injury. Journal of the American Society of Nephrology 7, 897-905 (1996).
50. Nakayama, Y. et al. Long-term observation of renal function on combination therapy with prostaglandin and angiotensinconverting enzyme inhibitor for chronic kidney disease. Clinical nephrology 69, 402-407 (2008).
51. Mahmoud, I. M., Hussein Ael, A., Sarhan, M. E., Awad, A. A. & El Desoky, I. Role of combined L-arginine and prostaglandin E1 in renal ischemia-reperfusion injury. Nephron Physiol 105, p57-65, https://doi. org/10. 1159/000100425 (2007).
52. Chavez, J. A. et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278, 10297-10303, https://doi. org/10. 1074/jbc. M212307200 (2003).
53. Reynolds, A. et al. Induction of the interferon response by siRNA is cell type-and duplex length-dependent. Rna-a Publication of the Rna Society 12, 988-993 (2006).
54. Ji, K. et al. Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1alpha pathway. Free Radic Biol Med 84, 161-170, https://doi. org/10. 1016/j. freeradbiomed. 2015. 03. 020 (2015).
55. Choi, S. E. et al. Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology 150, 126-134, https://doi. org/10. 1210/en. 2008-0483 (2009).
56. Reed, M. J. et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49, 1390-1394, https://doi. org/10. 1053/meta. 2000. 17721 (2000).
57. Bonora, E. et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes care 23, 57-63 (2000).
58. Okita, K. et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocrine journal 60, 283-290 (2013).